Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators-Reference-Cited by-同舟云学术

Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators

Published:2017-06-06 Issue:23 Volume:135 Page:2310-2312
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Lampert Rachel¹,Olshansky Brian¹,Heidbuchel Hein¹,Lawless Christine¹,Saarel Elizabeth¹,Ackerman Michael¹,Calkins Hugh¹,Estes N.A. Mark¹,Link Mark S.¹,Maron Barry J.¹,Marcus Frank¹,Scheinman Melvin¹,Wilkoff Bruce L.¹,Zipes Douglas P.¹,Berul Charles I.¹,Cheng Alan¹,Jordaens Luc¹,Law Ian¹,Loomis Michele¹,Willems Rik¹,Barth Cheryl¹,Broos Karin¹,Brandt Cynthia¹,Dziura James¹,Li Fangyong¹,Simone Laura¹,Vandenberghe Katleen¹,Cannom David¹

Affiliation:

1. From Yale University School of Medicine, New Haven, CT (R.L., C.B., J.D., F.L., L.S.); University of Iowa, Iowa City (B.O., I.L.); Antwerp University and University Hospital, Belgium (H.H.); Sports Cardiology Consultants LLC, Chicago, IL (C.L.); Cleveland Clinic, OH (E.S., B.L.W.); Mayo Clinic, Rochester, MN (M.A.); Johns Hopkins University, Baltimore, MD (H.C., A.C.); Tufts Medical Center, Boston, MA (N.A.M.E., B.J.M.); UT Southwestern, Dallas, TX (M.S.L.); University of Arizona, Tucson (F.M.);...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference5 articles.

1. Introduction: Eligibility recommendations for competitive athletes with cardiovascular abnormalities—general considerations

2. Recommendations for competitive sports participation in athletes with cardiovascular disease: A consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology

3. Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators

4. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects

5. Exercise Increases Age-Related Penetrance and Arrhythmic Risk in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy–Associated Desmosomal Mutation Carriers

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The differentiation of the competitive athlete with physiologic cardiac remodeling from the athlete with cardiomyopathy;Current Problems in Cardiology;2024-09

2. Redefining Management in Hypertrophic Cardiomyopathy: The Role and Challenges of Exercise Rehabilitation;Cardiology in Review;2024-08-23

3. Vigorous Exercise in Patients with Hypertrophic Cardiomyopathy;Current Sports Medicine Reports;2024-07

4. JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia;Journal of Arrhythmia;2024-06-12

5. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines;Circulation;2024-06-04